Skip to main content

Table 1 Patient demographics and clinical history

From: Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia

Baseline characteristics Psychometric Validation Sample Qualitative Content Validation Sample
Ferumoxytol (n = 608) Placebo (n = 200)
Age, years, mean (± SD) 44.8 (±13.82) 46.0 (±13.58) 41.7 (±11.3)
Female, n (%) 542 (89.1) 178 (89.0) 14 (93.3)
Race, n (%)    
Asian 98 (16.1) 32 (16.0) -
Black/African American 152 (25.0) 50 (25.0) 11 (73.3)
White 340 (55.9) 111 (55.5) 4 (26.7)
Other/Multiracial 18 (3.0) 7 (3.5) -
Hgb g/dL, mean (± SD) 8.9 (±0.89) 8.8 (±0.89) -
TSAT, mean (± SD) 7.0 (12.9) 5.4 (4.9) -
Underlying condition, n (%)    
AUB 260 (42.8) 84 (42.0) 11 (73.3)
Cancer 29 (4.8) 10 (5.0) -
GI disorders 173 (28.5) 58 (29.0) 1 (6.7)
Postpartum anemia 4 (0.7) 0 (0.0) 2 (13.3)
Other a 142 (23.4) 48 (24.0) 1 (6.7)
FACIT-fatigue, mean (± SD) 24.1 (11.8) 24.7 (11.3) -
  1. SD = Standard Deviation; n = sample size; Hgb = hemoglobin; TSAT = transferrin saturation; AUB = abnormal uterine bleeding; GI = gastro-intestinal
  2. a Other included nutritional iron deficiency, heart failure, and rheumatoid arthritis